9n9l: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
The entry 9n9l is ON HOLD | The entry 9n9l is ON HOLD until Paper Publication | ||
Authors: Spurlino, J.C., Milligan, C. | Authors: Spurlino, J.C., Milligan, C. | ||
| Line 7: | Line 7: | ||
Description: An RORgt Inverse agonist for treatment of Psoriasis | Description: An RORgt Inverse agonist for treatment of Psoriasis | ||
[[Category: Unreleased Structures]] | [[Category: Unreleased Structures]] | ||
[[Category: Spurlino, J.C]] | |||
[[Category: Milligan, C]] | [[Category: Milligan, C]] | ||
Revision as of 20:19, 26 March 2025
Unreleased structure
The entry 9n9l is ON HOLD until Paper Publication
Authors: Spurlino, J.C., Milligan, C.
Description: An RORgt Inverse agonist for treatment of Psoriasis
